Pierfranco F. Spano

Brescia, 25123, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.

Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.

Journal: Acta neuropathologica

Published: February 08, 2018

Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.

Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.

Journal: International journal of molecular sciences

Published: November 10, 2017

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?

Journal: Genes

Published: October 31, 2017

Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.

Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.

Journal: Handbook of experimental pharmacology

Published: October 02, 2017

Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons.

Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons.

Journal: The Journal of pharmacology and experimental therapeutics

Published: September 14, 2017

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.

Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.

Journal: Neural plasticity

Published: August 07, 2017

The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.

The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.

Journal: Frontiers in aging neuroscience

Published: August 02, 2017

Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.

Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.

Journal: Brain pathology (Zurich, Switzerland)

Published: July 20, 2017

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation.

Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation.

Journal: International journal of molecular sciences

Published: October 11, 2016

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy.

Journal: Neural plasticity

Published: August 04, 2016

Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.

Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.

Journal: Molecular neurobiology

Published: July 04, 2016

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.

Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.

Journal: Molecular psychiatry

Published: July 04, 2016

Showing 1-12 of 29

Last Updated: 09/26/2026